Allogene Therapeutics, Inc.

ALLO

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001737287

SEC filings (opens in a new tab)

In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Allogene Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of ALLO: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Q4 2024	Change
Holders	156	174	+18
Shares	164.4M	188.7M	+24.3M (+14.8%)
Value	$460.4M	$401.9M	−$58.5M (−12.7%)

New holders (32)

Institutions that held Allogene Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ALLO in Q4 2024
Institution	Shares	Value	% of portfolio
Pfizer Inc	22,032,040	$46.9M	1.81%
Foresite Capital Management VI LLC	3,448,275	$7.34M	3.27%
Patient Square Capital LP	1,489,909	$3.17M	1.19%
Gilead Sciences, Inc.	1,156,689	$2.46M	0.16%
Raiffeisen Bank International AG	430,000	$903.0K	0.01%
Susquehanna Fundamental Investments, LLC	376,661	$802.3K	0.01%
Standard Life Aberdeen plc	364,382	$776.1K	0.00%
Harold Davidson & Associates Inc.	232,615	$495.5K	0.24%
XTX Topco Ltd	158,537	$337.7K	0.03%
SEI Investments Co	48,320	$102.9K	0.00%
Graham Capital Management, L.P.	41,737	$88.9K	0.00%
Police & Firemen's Retirement System of New Jersey	29,791	$63.5K	0.00%
KLP Kapitalforvaltning AS	20,400	$43.5K	0.00%
Syon Capital LLC	18,351	$39.1K	0.00%
Caption Management, LLC	15,000	$31.9K	0.00%
Rpo LLC	14,787	$31.5K	0.04%
PAX Financial Group, LLC	12,832	$27.3K	0.00%
CIBC World Markets Corp	12,013	$25.6K	0.00%
Boothbay Fund Management, LLC	11,090	$23.6K	0.00%
Mainstream Capital Management LLC	7,450	$15.9K	0.01%
GF Fund Management Co. Ltd.	4,403	$9.38K	0.00%
Russell Investments Group, Ltd.	587	$1.25K	0.00%
Ball & Co Wealth Management Inc.	500	$1.00K	0.00%
SBI Securities Co., Ltd.	425	$905	0.00%
UMA Financial Services, Inc.	321	$684	0.00%
Pinney & Scofield, Inc.	192	$409	0.00%
Caitong International Asset Management Co., Ltd	150	$320	0.00%
Optiver Holding B.V.	137	$292	0.00%
R Squared Ltd	110	$234	0.00%
Toronto Dominion Bank	27	$58	0.00%
Lindbrook Capital, LLC	9	$19	0.00%
MAI Capital Management	1	$2	0.00%

Sold out (14)

Institutions that held Allogene Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of ALLO in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Perceptive Advisors LLC	2,725,000	$7.63M
ExodusPoint Capital Management, LP	1,634,838	$4.58M
Superstring Capital Management LP	478,115	$1.34M
Millennium Management LLC	258,002	$722.4K
Prudential Financial Inc	214,495	$600.6K
Alps Advisors Inc	175,285	$490.8K
Engineers Gate Manager LP	47,773	$133.8K
AQR Capital Management LLC	33,589	$94.0K
Cornercap Investment Counsel Inc	28,533	$79.9K
Private Advisor Group, LLC	12,087	$33.8K
Amundi	8,011	$21.9K
nVerses Capital, LLC	3,100	$8.68K
Comerica Bank	1,916	$5.37K
Capital Performance Advisors LLP	41	$115